Mergers and Acquisitions

Takeda’s £46B Shire Buy Gets Nod From Chinese Regulator

Japanese pharmaceutical giant Takeda announced Friday that Chinese regulators have given their “unconditional clearance” for a planned £46 billion ($60 billion) acquisition of Dublin's Shire, the rare disease-focused drugmaker. ...read more